We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Sarah Whelan, PhD

Sarah Whelan, PhD

Science Writer


Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.


Got a Question for Sarah Whelan, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 264
A bowl of white pills.
News

Metformin Use Linked to Reduced Blood Cancer Risk, Study Finds

A new study from Denmark has found that people taking the type 2 diabetes drug metformin are less likely to develop a myeloproliferative neoplasm (MPN) – a rare type of blood cancer that can develop into acute leukemia.
An image of a brain.
News

Protein Linked to Alzheimer’s May Shape Neuron Growth

A new study has described how a protein that helps to shape the growth of neurons – contactin-4 – also interacts with a protein involved in neurodevelopmental diseases and Alzheimer’s.
A scientist holding up a vial containing an image of a DNA double helix.
Article

Top Trends Shaping Pharma in 2024: AI, Gene Editing, Biosimilars and Real-World Data

From AI's transformative role in drug discovery and CRISPR breakthroughs to the rise of biosimilars and real-world data. Learn how these innovations are reshaping pharma and driving progress in 2024.
Synthetic Biology in Medicine infographic snippet
Infographic

Synthetic Biology in Medicine

Download this infographic to learn about medical applications for synthetic biology, such as diagnostics and biosensors, cell therapy and precision medicine, and synthetic bacterial therapeutics.
A vitamin D capsule.
News

Is Vitamin D Supplementation Really One-Size-Fits-All?

A new study suggests the need for personalized approaches to supplementation to help reduce vitamin D deficiency, which remains widespread despite extensive research.
An abstract image of a person with flowers growing from their head.
News

Researchers Uncover How Psychedelics Interact With Serotonin Receptors

Researchers have shed light on how some psychedelic drugs – which show promise in patients with neuropsychiatric disorders such as depression and anxiety – bind to and activate serotonin receptors.
A needle inserted into a vaccine vial.
News

Experimental mRNA Brain Cancer Vaccine Evaluated in Small Trial

A new mRNA vaccine has shown promise in activating the immune system against a highly lethal type of brain tumor, according to results from a first-in-human clinical trial of four adult patients with glioblastoma.
A person putting a pill to their lips.
News

Acid Reflux Drugs Linked to Higher Migraine Risk, Study Finds

Some drugs used to treat acid reflux may also increase the risk of migraines and other severe headaches, a new study finds. The drugs include prescription proton pump inhibitors – such as omeprazole – as well as H2 blockers and antacid supplements.
Dr. Khadijah A. Mitchell
Article

Cancer Research, Mentorship and Confidence in Your Competence With Dr. Khadijah A. Mitchell

Cancer researcher Dr. Khadijah A. Mitchell reflects on her journey into studying health disparities, touches on the importance of mentorship and shares some inspiring advice for women and girls considering a career in STEMM.
A lab worker pipetting media into a cell culture dish.
Industry Insight

Recreating Organ-Specific Tumor Environments In Vitro

At ELRIG’s Research & Innovation 2024 event, Technology Networks spoke to Dr. Véronique De Conto, project leader in in vitro pharmacology at HCS Pharma, to learn more about their powerful tools for in vitro metastasis propagation.
Advertisement